Diagnoses | n | AD | VaD | FTLD | LBD | TBI | ARD | HD | PDD | NPH | CJD | HIV | MD |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
References | |||||||||||||
[19] | 200 | 54(27%) | 33(17%) | 7(4%) | 4(2%) | NR | 12(6%) | 3(1.5%) | 2(1%) | 1(0.5%) | NR | NR | NR |
[20] | 132 | 59(45%) | 16(12%) | 9(7%) | NR | NR | 19(14%) | NR | NR | NR | NR | NR | NR |
[21] | 185 | 62(34%) | 34(18%) | 23(12%) | 12(7%) | EX | 19(10%) | 9(5%) | 2(1%) | NR | NR | NR | NR |
[28] | 141 | 30(21%) | 52(37%) | 7(5%) | NR | 13(9.2%) | NR | NR | NR | 6(4.2%) | NR | NR | NR |
[49] | 76 | 10 (13%) | 33(44%) | NR | NR | NR | NR | NR | NR | NR | NR | 3(4%) | 7(9.2%) |
[13] | 34 | 13(38.2%) | 8(23.8%) | 5(14.7%) | 1(2.9%) | 3(8.8%) | NR | NR | NR | NR | NR | NR | 2(5.9%) |
[4] | 278 | 48(17%) | 80(29%) | 7(3%) | NR | 67(24%) | 15(5%) | 4(1%) | NR | 6(2%) | 1(<1%) | 22(8%) | NR |
[22] | 185 | 71(38.5%) | 23(12.6%) | 40(21.4%) | 1(0.5%) | 9(4.9%) | NR | NR | NR | NR | NR | NR | 2(1%) |
[29] | 112 | 27(11.9%) | 7(3.1%) | 43(19%) | 1(0.4%) | 4(1.8%) | 6(2.7%) | EX | 3(1.3%) | NR | 5(2.2%) | 1(0.4%) | NR |
[17] | 235 | 4(1%) | 14(5.9%) | 31(13.19%) | NR | EX | 1(<1%) | 18(7.6%) | 1(<1%) | 4(1%) | NR | NR | NR |
[23] | 54 | 19(35.2%) | 6(11.1%) | 16(26.62%) | NR | NR | NR | 9(16.6%) | NR | NR | NR | NR | NR |
[18] | 69 | 46(66.7%) | 3(4.3%) | 7(10.1%) | 1(1.4%) | NR | NR | NR | NR | NR | NR | NR | NR |
[26] | 93 | 31(33%) | 19(20%) | 25(27%) | NR | NR | NR | 4(4%) | 4(4%) | NR | NR | NR | NR |
[24] | 114 | 31(27.2%) | 7(6.1%) | 28(24.6%) | 3(2.6%) | NR | NR | 3(2.6%) | 2(1.8%) | NR | 6(5.3%) | NR | NR |
[27] | 617 | 158(25.6%) | 262(42.5%) | 16(2.6%) | NR | NR | 3(2.8%) | NR | NR | NR | NR | NR | NR |
[25] | 144 | 61(42.4%) | 20(13.8%) | 14(9.7%) | 1(<1%) | 2(1.3%) | 5(3.4%) | 3(2%) | 3(2%) | NR | 2(1.3%) | NR | 9(6.3%) |